Antibody that neutralizes sMIC boosts CTLA4 immunotherapy response and reduces colitis – EurekAlert (press release)
EurekAlert (press release) |
Antibody that neutralizes sMIC boosts CTLA4 immunotherapy response and reduces colitis
EurekAlert (press release) Researchers have developed a therapy to block CTLA4, specifically, anti-CTLA4 antibody immunotherapy, to help sustain T-cell activation and improve patient survival. Unfortunately, while anti-CTLA4 therapy is highly effective in animals, response rates … |
